The sky is truly the limit with BioSens-All technology.

The extensive experience of our staff scientists in the development of BRET-based assays makes it possible to address numerous questions regarding the function, localization and/or activity of your target(s) of interest. Following stringent validation, all newly developed assays can be performed at Domain Therapeutics NA, or can be out-licensed exclusively to the client.